文献速递泌尿生殖胸部心血管US

肺超声在血液透析患者超滤量调整中的作用

Role of Lung Ultrasound in Adjusting Ultrafiltration Volume in Hemodialysis Patients.
PubMed 文献 · Ultrasound Med Biol · 2018-12-14

研究纳入35例血液透析患者,透析前后行胸部超声、胫前皮肤组织厚度、心脏及下腔静脉超声检查,比较透析前后B线评分、下腔静脉直径及心功能,并前瞻性根据B线评分调整超滤量。结果显示超滤量主要与B线评分相关,透析后B线评分与左室射血分数及胫前皮肤组织厚度相关。

要点

  • 透析前后B线评分中位数分别为10(0-42)和4(0-30),透析中下降(p<0.001)。
  • 超滤量调整与B线评分独立相关(β=-3.340;p=0.003),与心功能、下腔静脉直径、下腔静脉塌陷率或胫前皮肤组织厚度无关。
  • 前次透析B线评分>6时前瞻性增加超滤量,所有患者耐受良好且无症状。

核心结论

  • 超滤量主要与肺水相关,反映为B线评分的变化;与心功能、下腔静脉直径、下腔静脉塌陷率或胫前皮肤组织厚度无关。
  • 肺超声是透析患者有用的影像工具。

研究设计与样本

  • 研究类型为在35例血液透析患者中开展的前瞻性研究。
  • 透析前后行胸部超声、胫前皮肤组织厚度、心脏及下腔静脉超声检查,并前瞻性调整后续透析的超滤参数。
  • 参考标准为超滤量,比较透析前后B线评分、下腔静脉直径及心功能参数。

关键影像表现/征象

  • 透析中B线评分中位数由10(0-42)降至4(0-30)(p<0.001)。
  • 二尖瓣血流速度E由0.83±0.23 m/s降至0.70±0.20 m/s(p<0.001),A由0.93±0.28 m/s降至0.89±0.23 m/s(p<0.001),E/e'由12.47±4.92降至10.37±4.0(p<0.001)。
  • 呼气末下腔静脉直径由17.51±3.33 mm降至14.26±3.45 mm(p<0.001)。
  • 右侧胫前皮肤组织厚度由2.86±1.36 mm降至2.43±1.24 mm(p<0.001)。

诊断标准与关键数值

  • 超滤量(校正年龄和性别)与B线评分相关(β=-3.340;p=0.003)。
  • 透析后B线评分与左心室射血分数相关(r=-0.393;p=0.019),与胫前皮肤组织厚度相关(r=-0.447;p=0.007)。
  • 前次透析B线评分>6时前瞻性增加超滤量。

临床应用与阅片要点

  • 原文未据此给出推荐。
  • 研究方案为前次透析B线评分>6时前瞻性增加超滤量,所有患者耐受良好且无症状。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Chronic fluid over-hydration is common in dialysis patients. It is associated with mortality and cardiovascular events. Optimal methods for adjusting fluid volume status and ideal dry weight remain uncertain. The purpose of this study was to evaluate the usefulness of ultrasound in quantifying body water. In 35 hemodialysis patients, we performed ultrasound of the chest, pre-tibial skin tissue thickness (TT), heart and inferior vena cava (IVC) before and after dialysis. We compared B-line scores of lungs, IVC diameters and cardiac functions in pre-dialysis and post-dialysis groups. We then estimated the correlations between ultrasound parameters and ultrafiltration volumes. Ultrafiltration parameters were adjusted prospectively for subsequent dialysis. As a result, both extravascular and intravascular water decreased during ultrafiltration. The median numbers of B-line scores (10 [0-42] vs. 4 [0-30]; p < 0.001); mitral valve blood flow velocities E (0.83 ± 0.23 m/s vs. 0.70 ± 0.20 m/s; p < 0.001), A (0.93 ± 0.28 vs. 0.89 ± 0.23 m/s; p < 0.001) and E/e' (12.47 ± 4.92 vs. 10.37 ± 4.0; p < 0.001); IVC diameters at end-expiration (17.51 ± 3.33 mm vs. 14.26 ± 3.45 mm; p < 0.001); and right pre-tibial TT (2.86 ± 1.36 mm vs. 2.43 ± 1.24 mm; p < 0.001) decreased during dialysis. Ultrafiltration volume was most associated with B-line score (adjusting for age and sex) (β = -3.340; p = 0.003). In addition, the B-line score after dialysis was significantly associated with left ventricular ejection fraction (r = -0.393; p = 0.019) and TT (r = -0.447; p = 0.007). Ultrafiltration volume was prospectively increased then if the B-line score was >6 in the previous dialysis. All patients tolerated the protocol well without any symptoms. Ultrafiltration volume was most associated with lung water, reflected by variation in B-line score. It was not associated with cardiac function, IVC diameter, IVC collapse rate or TT. Lung ultrasound is a useful imaging tool for dialysis patients.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Liang XK, Li LJ, Wang XH, et al. Role of Lung Ultrasound in Adjusting Ultrafiltration Volume in Hemodialysis Patients. Ultrasound Med Biol. 2018. PMID: 30558830. doi:10.1016/j.ultrasmedbio.2018.10.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。